B-Myb protein in cellular proliferation, transcription control, and cancer: Latest developments

Journal of Cellular Physiology

Volumn 179, Issue 3, 1999, Pages 245-250

  Sala, Arturo ^a,b   Watson, Roger ^c  

^a Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^b CMNS   (Italy)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

CANCER; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REVIEW; TRANSCRIPTION REGULATION;

CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0032960409     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199906)179:3<245::AID-JCP1>3.0.CO;2-H     Document Type: Review

References (49)

1. Ansieau S, Kowentz-Leutz E, Dechend R, Leutz A. 1997. B-Myb, a repressed trans-activating protein. J Mol Med 75:815-819.
2. Arsura M, Introna M, Passerini F, Mantovani A, Golay J. 1992. B-myb antisense oligonucleotides inhibit proliferation of Phuman hematopoietic cell lines. Blood 79:2708-2716.
3. Bennett JD, Farlie PG, Watson RJ. 1996. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene 13:1073-1082.
4. Bies J, Hoffman B, Amanullah A, Giese T, Wolff L. 1996. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12:355-363.
5. Burk O, Mink S, Ringwald M, Klempnauer K-H. 1993. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 12:2027-2038.
6. Dash AB, Orrico FC, Ness SA. 1996. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb.
7. Engelke UL, Whittaker L, Lipsick JS. 1995. Weak transcriptional activation is sufficient for transformation by v-myb. Virology 208: 467-477.
8. Foos G, Grimm S, Klempnauer K-H. 1992. Functional antagonism between members of the myb family: B-myb inhibits v-myb-induced gene activation. EMBO J 11:4619-4629.
9. Foos G, Natour S, Klempnauer K-H. 1993. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins. Oncogene 8:1775-1782.
10. Golay J, Capucci A, Arsura M, Castellano M, Rizzo V, Introna M. 1991. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77:149-158.
11. Golay J, Cusmano G, Introna M. 1992. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J Immunol 49(1): 300-308.
12. Golay J, Luppi M, Songia S, Palvarini C, Lombardi L, Aiello A, Delia D, Lam K, Crawford DH, Biondi A, Barbui T, Rambaldi A, Introna M. 1996. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, slg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood 87:1900-1911.
13. Golay J, Brocolli V, Borleri G-M, Erba E, Faretta M, Basilico L, Ying G-G, Picchini G, Shapiro L, Lovric J, Nawrath M, Mölling K, Rambaldi A, Introna M. 1997. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells. Cell Growth Differ 8:1305-1316.
14. Golay J, Broccoli V, Lamorte G, Bifulco C, Parravicini C, Pizzey A, Thomas NSB, Delia D, Ferrauti P, Vitolo D, Introna M. 1998. The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol 160:2786-2793.
15. Graf T. 1992. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr Opin Genet Dev 2:249-255.
16. Hurford RK, Cobrinik D, Lee M-H, Dyson N. 1997. pRB and p107/ p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11:1447-1463.
17. Ibanez CE, Lipsick JS. 1990. Trans activation of gene expression by v-myb. Mol Cell Biol 10:2285-2293.
18. Kamano H, Klempnauer K-H. 1997. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter. Oncogene 14:1223-1229.
19. Kamano H, Burk B, Noben-Trauth K, Klempnauer K-H. 1995. Differential splicing of the mouse B-myb gene. Oncogene 11:2575-2582.
20. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingston DM. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
21. Lam EW-F, Watson RJ. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J 12: 2705-2713.
22. Lam EW-F, Robinson C, Watson RJ. 1992. Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene 7:1885-1890.
23. Lane S, Farlie P, Watson R. 1997. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation. Oncogene 14:2445-2453.
24. Latham KE, Litvin J, Orth JM, Patel B, Mettus R, Reddy EP. 1996. Temporal patterns of A-myb and B-myb gene expression during testis development. Oncogene 13:1161-1168.
25. Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E, Mercer WE. 1994. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc Natl Acad Sci USA 91:10079-10083.
26. Marhamati DJ, Sonenshein GE. 1996. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type 1 collagen genes. J Biol Chem 271(7):3359-3365.
27. McIntosh PB, Frenkiel TA, Wolborn U, McCormick JE, Klempnauer K-H, Feeney J, Carr MD. 1998. Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression. Biochemistry 37:9619-9629.
28. Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G, Ishii S. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7:1233-1240.
29. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A. 1993. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 7:749-759.
30. Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S, Ishizaki R. 1988. Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res 16:11075-11089.
31. Nomura T, Sakai N, Sarai A, Sudo T, Kanei-Ishii C, Ramsay R, Favier D, Gonda TJ, Ishii S. 1993. Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem 268:21914-21923.
32. Oh I-H, Reddy EP. 1998. The C-terminal domain of B-Myb acts as a positive regulator of transcription and modulates its biological functions. Mol Cell Biol 18:499-511.
33. Pfitzner E, Kirfel J, Becker P, Rolke A, Schule R. 1998. Physical interaction between retinoic acid receptor and the oncoprotein myb inhibits retinoic acid-dependent transactivation. Proc Natl Acad Sci USA 96:5539-5544.
34. Raschellà G, Negroni A, Sala A, Pucci S, Romeo A, Calabretta B. 1995. Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J Biol Chem 270:8540-8545.
35. Raschellà G, Negroni A, Pucci S, Amendola R, Valeri S, Calabretta B. 1996. B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells. Exp Cell Res 222:395-399.
36. Reiss K, Travali S, Calabretta B, Baserga R. 1991. Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J Cell Physiol 148:338-343.
37. Robinson C, Light Y, Groves R, Mann D, Marias R, Watson R. 1996. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle. Oncogene 12:1855-1864.
38. Sala A, Calabretta B. 1992. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc Natl Acad Sci USA 89:10415-10419.
39. Sala A, Casella I, Bellon T, Calabretta B, Watson RJ, Peschle C. 1996a. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J Biol Chem 271:9363-9367.
40. Sala A, De Luca A, Giordano A, Peschle C. 1996b. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity. J Biol Chem 271:28738-28740.
41. Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K, Peschle C. 1997. Activation of human B-MYB by cyclins. Proc Natl Acad Sci USA 94:532-536.
42. Sala A, Saitta B, DeLuca P, Cervellera M, Casella I, Watson R, Peschle C. 1999. B-MYB autoregulates its own promoter through the SP1-binding site. Oncogene 18:1333-1340.
43. Saville MK, Watson RJ. 1998. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/cdk2 at sites that enhance its transactivation properties. Oncogene 17:2679-2689.
44. Seeger R, Reynolds C. 1993. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, editors. Cancer medicine, Philadelphia: Lea and Febiger. p 2172-2184.
45. Sitzmann J, Noben-Trauth K, Kamano H, Klempnauer K-H. 1996. Expression of B-Myb during mouse embryogenesis. Oncogene 12: 1889-1894.
46. Thompson CB, Challoner PB, Neiman PE, Groudine M. 1986. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319:374-380.
47. Watson RJ, Robinson C, Lam E-WF. 1993. Transcription regulation by murine B-myb is distinct from that by c-myb. Nucleic Acids Res 21:267-272.
48. Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda M, Aaronson SA, Wong-Staal F. 1982. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci USA 79: 2194-2198.
49. Ziebold U, Bartsch O, Marais R, Ferrari S, Klempnauer K-H. 1997. Phosphorylation and activation of B-Myb by cyclin A-Cdk2. Curr Biol 7:253-260.